EA
NVO

Eudaimonia Advisors’s Novo Nordisk NVO Stock Holding History

Eudaimonia Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.68M Buy
+28,651
New +$3.41M 1.96% 10

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eudaimonia Advisors's NVO Position: Q1 2024 in Review

Eudaimonia Advisors opened a new position in Novo Nordisk (NVO) in Q1 2024: 28,651 shares worth $3.68M. The stake represents 1.96% of the portfolio and ranks #10 among its holdings.

1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Eudaimonia Advisors held 28,651 shares of Novo Nordisk worth $3.68M as of Q1 2024.
  • Novo Nordisk was a new Eudaimonia Advisors position in Q1 2024.
  • Novo Nordisk made up 1.96% of Eudaimonia Advisors's portfolio in Q1 2024, its #10 holding.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.